Get started
Author

Pinghan Huang

Observed name: Ping‐Han Huang
ORCID: 0000-0003-2460-0695
Observed ORCID: 0000-0003-2460-0695
OpenAlex ID: A5023960259
Viromimetic STING Agonist‐Loaded Hollow Polymeric Nanoparticles for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus
2019 · Leon Chien‐Wei Lin, Chen‐Yu Huang, et al. · Advanced Functional Materials · 160
PDF
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations
2024 · Michael Westberg, Yichi Su, et al. · Science Translational Medicine · 46
Lymph Node Follicle‐Targeting STING Agonist Nanoshells Enable Single‐Shot M2e Vaccination for Broad and Durable Influenza Protection
2023 · Hsiao‐Han Tsai, Ping‐Han Huang, et al. · Advanced Science · 23
PDF
Superior replication, pathogenicity, and immune evasion of a Texas dairy cattle H5N1 virus compared to a historical avian isolate
2025 · Cassio Pontes Octaviani, Pinghan Huang, et al. · Scientific Reports · 13
Characterizing neuroinvasion and neuropathology of SARS-CoV-2 by using AC70 human ACE2 transgenic mice
2024 · Jason C. Hsu, Panatda Saenkham-Huntsinger, et al. · Frontiers in Microbiology · 9
PDF
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
2023 · Brandon Carter, Pinghan Huang, et al. · Frontiers in Immunology · 8
Characterizing temporal and global host innate immune responses against SARS-CoV-1 and -2 infection in pathologically relevant human lung epithelial cells
2025 · Vivian Y. Tat, Aleksandra K. Drelich, et al. · PLoS ONE · 3
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
2022 · Brandon Carter, Pinghan Huang, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 3
PDF
Evaluation of Type I Interferon Treatment in Hospitalized COVID-19 Patients: A Retrospective Cohort Study
2024 · Vivian Y. Tat, Pinghan Huang, et al. · Pathogens · 2
Design of SARS-CoV-2 protease inhibitors with improved affinity and reduced sensitivity to mutations
2023 · Michael Westberg, Yichi Su, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerization
2025 · Vincent H. J. Leonard, Dianna B. Vidales, et al. · Antimicrobial Agents and Chemotherapy
BALB/c mice challenged with SARS-CoV-2 B.1.351 β variant cause pathophysiological and neurological changes within the lungs and brains
2024 · Panatda Saenkham-Huntsinger, Aleksandra K. Drelich, et al. · Journal of General Virology
Induction of multivalent and balanced T cell responses by modular nanoshell vaccine technology
2023 · Pinghan Huang, Hsiao-Han Tsai, et al. · The Journal of Immunology
PDF
Works count: 13
Citation count: 268
H-index: 6
I10-index: 4
Year
Topic
Type